After several years of volatility and unfavorable market dynamics, the initial public offering (IPO) market for medical technology companies is beginning to reopen meaningfully. Following the most recent IPO boom in 2020 and 2021, higher interest rates and inflation brought new IPO issuances to a near standstill from 2022 to 2024. During that period, many
On Dec. 18, 2025, President Donald Trump signed the National Defense Authorization Act for Fiscal Year 2026 (NDAA) into law. The NDAA includes Section 8103, the Holding Foreign Insiders Accountable Act (HFIAA), which abolishes certain of the current exemptions for securities of foreign private issuers (FPIs) from compliance with certain provisions of the Securities Exchange
On March 3, 2025, the SEC’s Division of Corporation Finance issued new guidance expanding the availability of confidential review of draft registration statements (DRS). Originally, DRS was for foreign private issuers and later extended to emerging growth companies (EGCs) under the JOBS Act in 2012. In 2017, the SEC allowed all companies to use DRS for IPOs and initial listings. The 2025 guidance removes the “initial filing” limitation, allowing both private and public companies to submit DRS for confidential review.
Continue Reading SEC Expands Confidential Review Process for Draft Registration Statements
Seventy-six attorneys from global law firm Greenberg Traurig, LLP are recognized in the 2025 edition of the prestigious legal services directory Chambers Global Guide. The global guide also recognized the firm in 32 practice areas across 12 regions, including Israel.
Chambers and Partners, a UK–based publisher, selects attorneys for inclusion in its guides based
| 1. Strong U.S. Equity Markets, SPACs, and ETFs: The U.S. equity markets are likely to kick off the year strong, as a variety of players are expected to take advantage of the early days of the incoming presidential administration. This may lead to a flurry of deals, particularly during the first three quarters, as companies |
Greenberg Traurig represented Nuvo Group Ltd. (Nuvo Cares), a pioneer in remote pregnancy monitoring, in connection with completion of its business combination with LAMF Global Ventures Corp. I, a publicly traded special purpose acquisition company. The combined company has retained the Nuvo name, along with its existing management and operational structure. The company’s
Many Israeli and other non-U.S. companies continue to seek access to the expansive investor base provided by the U.S. capital markets through new securities offerings, both public and private, as well as through stock exchange listings and sponsored American depositary receipt programs. Greenberg Traurig’s Foreign Private Issuer Guide sets forth selected legal and practical considerations